来自印度北方邦的SARS-CoV-2的基因组流行病学

Gauri Misra1, Ashrat Manzoor2, Meenu Chopra3

  • 1Molecular Diagnostics and COVID-19 Kit Testing Laboratory, National Institute of Biologicals (Ministry of Health and Family Welfare), A-32, Sector-62, Institutional Area, Noida, UP, 201309, India. gauri.misra@nib.gov.in.

Scientific reports
|September 8, 2023
PubMed
概括

西北邦的基因组监测确定了类似于Omicron BA.2的 (55.55%) 和Delta B.1.617.2 (45.5%) 作为主要的SARS-CoV-2菌株. 这项研究强调了融合进化,并为流行病准备提供了洞察力.